AVTX
NASDAQ · Biotechnology
Avalo Therapeutics Inc
$18.88
-0.57 (-2.93%)
Analyst Consensus
Strong Buy
21
Analysts
High
Coverage
Price Target
Analyst Price Target
+74.3% upside
Low Target
$27.78
Average Target
$32.91
High Target
$47.11
Current Price
$18.88
Current
$18.88
$18.88
Target
$32.91
$32.91
$27.78
$32.91 avg
$47.11
Scenario Analysis
Bear Case
$27.78
47.1%
Low target
Base Case
$32.91
+74.3%
Avg target
Bull Case
$47.11
+149.5%
High target
Risk/Reward
3.2x
Highly favorable
Price in Context
52-Week High
$24.27
-22.2% from high
52-Week Low
$8.41
+124.5% from low
Target vs 52W High
$32.91
+35.6% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |